Infection with dengue-2 virus alters proteins in naturally expectorated saliva of Aedes aegypti mosquitoes by Daniel M Chisenhall et al.
Chisenhall et al. Parasites & Vectors 2014, 7:252
http://www.parasitesandvectors.com/content/7/1/252RESEARCH Open AccessInfection with dengue-2 virus alters proteins in
naturally expectorated saliva of Aedes aegypti
mosquitoes
Daniel M Chisenhall1, Rebecca C Christofferson1, Michael K McCracken1, Ann-Marie F Johnson1,
Berlin Londono-Renteria1 and Christopher N Mores1,2*Abstract
Background: Dengue virus (DENV) is responsible for up to approximately 300 million infections and an increasing
number of deaths related to severe manifestations each year in affected countries throughout the tropics. It is
critical to understand the drivers of this emergence, including the role of vector-virus interactions. When a
DENV-infected Aedes aegypti mosquito bites a vertebrate, the virus is deposited along with a complex mixture
of salivary proteins. However, the influence of a DENV infection upon the expectorated salivary proteome of its
vector has yet to be determined.
Methods: Therefore, we conducted a proteomic analysis using 2-D gel electrophoresis coupled with mass
spectrometry based protein identification comparing the naturally expectorated saliva of Aedes aegypti infected
with DENV-2 relative to that of uninfected Aedes aegypti.
Results: Several proteins were found to be differentially expressed in the saliva of DENV-2 infected mosquitoes, in
particular proteins with anti-hemostatic and pain inhibitory functions were significantly reduced. Hypothetical
consequences of these particular protein reductions include increased biting rates and transmission success, and
lead to alteration of transmission potential as calculated in our vectorial capacity model.
Conclusions: We present our characterizations of these changes with regards to viral transmission and mosquito
blood-feeding success. Further, we conclude that our proteomic analysis of Aedes aegypti saliva altered by DENV
infection provides a unique opportunity to identify pro-viral impacts key to virus transmission.
Keywords: Ae. aegypti, Dengue, Arbovirus infection, Transmission, Mosquito saliva, Salivary proteins,
Transmission enhancement, Vectorial capacity modelingBackground
Arboviral diseases are major burdens on the health of
individuals and economies throughout the tropics and
subtropics [1]. Dengue virus (DENV) is critically respon-
sible for this impact, as it results in lost economic and
academic productivity due to millions of cases of dengue
fever, and it is the leading cause of childhood hospitali-
zations due to the severe manifestations of dengue
hemorrhagic fever and dengue shock syndrome each* Correspondence: cmores@lsu.edu
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article, unless otherwise stated.year [2,3]. Due to the establishment of Aedes aegypti
(Ae. aegypti) on the Portuguese island of Madeira,
throughout the Black Sea coastal region, south Florida
and several cities along the Gulf Coast in Texas and
Louisiana; the potential for both DENV and Ae. aegypti to
spread north as temperatures rise due to climate change is
a serious threat [4-6]. Indeed, recently, autochthonous
DENV transmission has been detected in Texas and
Florida, as well as in France, Portugal, and Croatia [7-11].
In order to better characterize vector-viral interactions
that might explain the expansion of DENV activity, several
studies have determined the vector competence of Ae.
aegypti with regards to DENV [12-14]. These determina-
tions are very important because they have allowedtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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of various mosquito and viral combinations have, although
the mechanisms behind observed differences remain elu-
sive. Consequently, in order to characterize these interac-
tions, some researchers have focused on exploring the
effect a DENV infection has upon Ae. aegypti transcrip-
tion, while others have focused on elucidating the impacts
within an immune-response context [15-17]. Still other
researchers have explored those interactions by massive
computational efforts, such as in silico data analysis utiliz-
ing a systems biology approach [18]. While the body of
information created in those efforts advance our under-
standing of the molecular events underpinning infection
outcome within Ae. aegypti, characteristics of vector-
pathogen interactions that directly impact DENV trans-
mission requires detailed consideration of the impact of
infection upon vector saliva.
When a DENV-infected Ae. aegypti bites a vertebrate,
the virus is deposited along with a complex mixture
of salivary proteins with diverse functions to facilitate
blood-feeding. Those proteins are known to be anti-
hemostatics, inhibitors of platelet aggregation, and
anti-vasoconstricitves; along with allergens and immune-
modulatory compounds [19-22]. Of particular importance
to the virus-vector-vertebrate interface is the role the in-
fection has on the salivary glands themselves, whose pro-
tein expression has been shown to be altered [23,24]. It
may be that the DENV infection of Ae. aegypti salivary
glands leads to an altered salivary expectorate, which when
delivered to the bite site along with virus may enhance
transmission success.
Accordingly, we investigated the ability of a DENV in-
fection to change the quality of Ae. aegypti saliva. We
characterized the proteins present in uninfected and
DENV-infected mosquitoes and compared the relative
abundance of matched proteins in each cohort. Herein,
we describe these analyses and provide detailed consid-
eration of the possible impacts DENV infection has
upon its vector leading to transmission enhancement.Methods
Virus
Dengue virus serotype-2 strain 1232 (DENV-2), origin-
ally isolated from a human patient in Jakarta, Indonesia
in 1978 and provided by the World Reference Center of
Emerging Viruses and Arboviruses, was previously pas-
saged 6 times through African green monkey kidney
(vero) cells before being used for this experiment.
Subsequently, it was inoculated on vero cells grown at
37°C and 5% CO2 in Medium-199 with Earle’s salts,
Penicillin/Streptomycin/Amphotericin B, and 10% fetal
bovine serum [24]. After 5 days, the supernatant was
harvested, titrated by plaque assay and qRT-PCR,and used at a concentration of 2.76x106 plaque-forming
units per mL [25].
Mosquitoes
Laboratory strain Ae. aegypti (Rockefeller) were main-
tained under constant environmental conditions (28°C
with a 16:8 light:dark photoperiod). The mosquitoes
were allowed to feed on bovine blood in Alsever’s
anticoagulant via Hemotek feeding device (Discovery
Workshops, Lancashire, England), after which the
blood-fed females were sorted and allowed to digest the
blood meal for 4 days. Six cartons, each containing
approximately 80 previously blood-fed females, were
then intrathoracically-inoculated using an EntoSphynx
Minucie (BioQuip, Rancho Dominguez, CA) dissecting
needle dipped in viral stock. The control group of equal
size (6 cartons of ~80 mosquitoes each) received an in-
oculation of media without virus.
Saliva collection
After a 10-day extrinsic incubation period, mosquitoes
were allowed to probe and feed on 1 mL of 1×
phosphate-buffered saline (PBS) and 10 mM adenosine
triphosphate (ATP) solution at 37°C in a Hemotek de-
vice for 1 hour; a variation on the technique developed
by Ribeiro, Rossignol, and Spielman [19]. This was re-
peated after 72 hours to obtain a larger volume of PBS/
ATP/saliva for downstream processing, approximately
12 mL. After the collection of saliva, the inoculated co-
hort was taken down and their legs were removed and
placed in 900 μL of BA-1 diluent for viral RNA extrac-
tion and detection via qRT-PCR [26]. Disseminated in-
fections were confirmed in >95% (n = 398/415) of the
mosquitoes which supplied the ‘infected’ saliva solutions.
From that dilute mixture, 200 μL fractions of the PBS/
ATP/saliva solution were added to 800 μL of acetone
chilled to −80°C and allowed to incubate at −20°C over-
night. The tubes were then centrifuged at 4°C at
10,000 rpm for 10 minutes to pellet the precipitated pro-
tein. The supernatant was discarded and the resulting
pellet was allowed to air-dry for 5 minutes at room
temperature. Once translucent, the pellet was then
reconstituted in 100 μL of 2-D rehydration buffer
(Bio-Rad) consisting of: 8 M urea, 2% CHAPS, 50 mM
dithiothreitol, 0.2% Bio-Lyte 3/10 ampholytes, and
0.001% bromophenol blue. The 100 μL of reconstituted
protein solution from the first tube was then used to
reconstitute the second pellet, further concentrating
the protein solution. This serial reconstitution was per-
formed no more than 5 times to minimize loss of reco-
very from over-saturation. The concentrated protein
solution still contained too much salt for 1st dimension
focusing; therefore the samples were processed through
a ReadyPrep 2-D cleanup kit (Bio-Rad) and resuspended
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were determined with a NanoDrop spectrophotometer
(Thermo Scientific).
2-D gel electrophoresis
30 μg of protein diluted in previously mentioned 2-D re-
hydration buffer to a final volume of 200 μL was loaded
per sample per 11 cm, pH 3–10 nonlinear IPG strip
(Bio-Rad) overlaid with approximately 2 mL of molecu-
lar biology-grade mineral oil (Bio-Rad) to prevent evap-
oration. First and second dimension electrophoresis
conditions, gel staining, and imaging methods were per-
formed as described previously [24].
Image analysis
Two gels from each experimental condition (for a total
of 4 gels) were analyzed to obtain both gel-to-gel differ-
ences between biological replicates and between experi-
mental conditions, “infected saliva” and “non-infected
saliva.” Pooling and sample size determination was per-
formed according to acceptable practices in 2D SDS-
PAGE and 2D DIGE proteomic analyses [24,27-31]. The
normalized spot density values for both gels from each
condition were used to determine the experimentally in-
duced fold changes. Gels were normalized as previously
described [24]. It is important to note that although
‘speckling’ did occur during staining and imaging, a
known artifact associated with SYPRO® Ruby staining,Figure 1 Analyzed protein spots. Representative Ae. aegypti saliva 2-D ge
strip) with the spots that were cut circled and numbered to match the IDsthe ‘speckle filter’ function of PDQuest was used to elim-
inate the small pixel intensity values from being included
in the normalization calculations [32]. This allowed de-
termination of the changes in protein spot abundance
due to our experimental treatment. The relative expres-
sion levels of the individual spots were evaluated by cal-
culating a fold-change value per spot as the infected
spot intensity divided by the uninfected control spot in-
tensity to determine the change relative to infection with
DENV-2. A representative gel image has been provided
with the spots excised for mass spectrometry analysis
marked and numbered for reference (Figure 1).
Mass spectrometry
After image analysis, a representative gel from each
group containing all of the spots of interest was sent to
the Nevada Proteomics Center at the University of
Nevada, Reno for robotic spot excision, trypsin digestion
and liquid chromatography-tandem mass spectrometry
(LC-MS/MS) analysis utilizing a Thermo LTQ Orbitrap
XL mass spectrometer with ETD coupled to a Michrom
Paradigm MDLC and Michrom CaptiveSpray (Thermo
Scientific). All MS/MS samples were analyzed using
Sequest (Thermo Fisher Scientific, San Jose, CA, USA;
version v.27, rev. 11). Sequest was set up to search an
Ae. aegypti database (35667 entries) downloaded from
Vectorbase.org and the non-redundant database ‘nr’
from NCBI for confirmation, assuming the digestionl image (12.5% Tris–HCl in TGS buffer using a pH 3–10 non-linear IPG
in Table 1.
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ment ion mass tolerance of 1.00 Da and a parent ion tol-
erance of 0.0068 Da to 0.041 Da, depending on the spot
analyzed. Iodoacetamide derivative of cysteine was speci-
fied in Sequest as a fixed modification. Oxidation of me-
thionine was specified in Sequest as a variable
modification.
Scaffold (version Scaffold_3.4.3, Proteome Software
Inc., Portland, OR) was used to validate MS/MS based
peptide and protein identifications. Peptide identifica-
tions were accepted if they could be established at
greater than 95.0% probability as specified by the Peptide
Prophet algorithm [34]. Protein identifications were ac-
cepted if they could be established at greater than 95.0%
probability and contained at least 2 identified peptides.
Protein probabilities were assigned by the Protein
Prophet algorithm [35]. Proteins that contained similar
peptides and could not be differentiated based on MS/
MS analysis alone were grouped to satisfy the principles
of parsimony.Transmission modeling
To demonstrate a potential consequence of altered saliv-
ary quality upon transmission measures, two parameters
were derived to account for the hypothetical difference
in the biting rate of infected versus uninfected mosqui-
toes and enhancement of transmission success. Using
the framework of vectorial capacity- a quantity that is
used to estimate the number of secondary infectious
bites resulting from a single, primary infectious bite-
measures the force of infection of mosquito to human
transmission [12,36]. The parameter values and vectorial
equations are given in Additional file 1: SI1. To isolate
the potential effects of the altered feeding environment
(rendered by the reduction of pain-inhibitory and anti-
hemostatic proteins in Ae. aegypti saliva), the daily biting
rate of uninfected mosquitoes was set at a = .63 [37],
while the biting rate of infected mosquitoes was investi-
gated over the range aINF = [.63-1.63]. Similarly, the
altered probability of transmission success rendered
by additional probing (and presumably deposition of
virus into the skin) was investigated by adding the
parameter t, which was varied from .7 to 1 [38]. The
addition of this parameter is based on the knowledge
that not all infectious bites result in a productive infec-
tion, and our hypothesis that additional feeding (through
increased salivation or separate bites) increases the prob-
ability of such. The change in vectorial capacity was
calculated by taking the difference between traditional
vectorial capacity calculation (where a = aINF) and this
new modified vectorial capacity (where a < aINF). The
magnitude of the potential enhancement of transmission
success was investigated over the range of t and thealteration of vectorial capacity expressed as the differ-
ence from tmin = .5 [38].
Results
Seventy-four spots were matched across the 4 gels cre-
ated from the cleaned-up, naturally-expectorated saliva.
Of those 74 spots, 23 spots were chosen to be analyzed
by mass spectrometry due to their being differentially
expressed or present in very high quantities, which
would be informative for land-marking purposes. The
proteins identified within those 23 excised and analyzed
spots were: a DEAD-box ATP-dependent RNA helicase,
beta chain spectrin, the hypothetical secreted protein
AAEL000748, adenosine deaminase, a putative adenosine
deaminase, apyrase, a putative apyrase, an inosine-uridine
preferring nucleoside hydrolase, a putative purine hydro-
lase, a salivary anti-FXa serpin, the hypothetical pro-
tein AAEL000732, a putative serine protease inhibitor
(Serpin-4), an angiopoietin-like protein variant, a putative
34kD family secreted salivary protein, D7 (3 spots), a puta-
tive D7, a low density lipoprotein receptor, a putative
30kD secreted protein (‘short-form aegyptin’), a venom al-
lergen/antigen 5, and a putative C-type lectin (2 spots).
Their respective fold-changes in the infected saliva, along
with accession numbers, are located in Table 1. The loca-
tions of these proteins in the gel can be found in Figure 1.
In addition, all mass spectrometry related data has been
included in the Additional file 2– Mass_Spec_Supplement.
To account for differences in the salivary proteins of in-
fected mosquitoes involved in anti-hemostatic and pain
responses at the bite site, modifications to the vectorial
capacity equation were made. The biting rate, which is
usually assumed to be the same for all mosquitoes, was es-
timated separately based on infection status. Accounting
for the increase in biting rate of infected mosquitoes rela-
tive to uninfected mosquitoes resulted in a linear increase
in vectorial capacity. The potential enhancement of trans-
mission success had a similarly linear effect, though since
this value is a probability, it is necessarily bounded by 1,
and thus its impact is also bounded. Taken together, these
changes in proteins could result in as many as two add-
itional infectious bites previously unaccounted for in trad-
itional parameterizations of vectorial capacity (Figure 2).
Discussion
The majority of the protein identifications determined
by mass spectrometry were for known or putative saliv-
ary proteins, a total of 16 out of 19 unique IDs [39,40].
The remaining three proteins with previously undetected
salivary roles (the DEAD-box ATP-dependent RNA heli-
case, beta chain spectrin, and the low density lipoprotein
receptor) could be present in this salivary sample due to
normal cell death in the salivary gland, as has been seen
previously [41]. Alternatively, these proteins may be being
Table 1 Identified proteins with accession numbers and fold change information
Ae. aegypti salivary proteins identified by mass spectrometry with fold change due to DENV infection
GenBank ID Protein name Spot Spot fold change
gi|108875535| DEAD-Box ATP-Dependent RNA Helicase‡ 1 −1.5
gi|108877982| Beta Chain Spectrin‡ 2 +1.0
gi|157109431| Hypothetical Secreted Protein AAEL000748‡ 3 −4.0
gi|108878609| Adenosine Deaminase 4 −2.8*
gi|18568326| Putative Adenosine Deaminase 5 −5.2*
gi|1094353| Apyrase‡ 6 −1.1
gi|108877845| Putative Apyrase‡ 7 +1.1
gi|108877687| Inosine-Uridine Preferring Nucleoside Hydrolase 8 −7.9*
gi|18568280| Putative Purine Hydrolase 9 −3.8*
gi|94468358| Salivary Anti-FXa Serpin 10 −4.8*
gi|157109433| Hypothetical Protein AAEL000732 11 −7.7*
gi|157131306| Putative Serine Protease Inhibitor (Serpin-4) 12 −19.4*
gi|94468352| Angiopoietin-Like Protein Variant‡ 13 −1.8
gi|94468642| Putative 34kD Family Secreted Salivary Protein‡ 14 −1.3
gi|222447044| D7‡ 15 −4.5
gi|222447044| D7‡ 16 −1.3
gi|222447044| D7‡ 17 −1.8
gi|108877064| Low Density Lipoprotein Receptor 18 −11.3*
gi|157113327| Putative D7‡ 19 −3.5
gi|18568322| Putative 30kD Secreted Protein; ‘Short-Form Aegyptin’ 20 −14.1*
gi|157110207| Antigen-5/Venom Allergen‡ 21 −2.5
gi|18568318| Putative C-Type Lectin‡ 22 N/A1
gi|18568318| Putative C-Type Lectin‡ 23 N/A1
*denotes significance at the p ≤ 0.05 level via Student’s t-test of the mean density of each spot between experimental conditions (n = 2 per condition).
1quantity at these spots were unable to be calculated due to the location of the bromophenol blue dye front in two of the four gels.
‡denotes proteins from spots chosen for mass spectrometry identification for the purposes of landmarking.
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as kratagonists, proteins that scavenge host hemostatic or
inflammatory system components [42,43]. For instance,
the ATP-binding motif present in the DEAD-box ATP-
dependent RNA helicase may be fortifying the function of
other ATP-degrading salivary proteins like apyrase [39,44].
Likewise, the low density lipoprotein receptor (LDL-r)
family has been shown to include members who are in-
volved in a diverse array of cellular functions, including
the LDL-r related protein (LRP)-type receptors which
regulate proteolytic processes involved in fibrinolysis
and coagulation [45]. It is interesting to note that in the
saliva of DENV-2 infected Ae. aegypti, this protein’s ex-
pression was reduced 11.3 fold, which was statistically
significant between treatment groups (p ≤ 0.05). In fact,
the Ae. aegypti low density lipoprotein receptor (gi|
108877064|) is more structurally similar to the mamma-
lian LRP receptor than the archetypal mammalian
LDL-r, according to the Conserved Domain Archetec-
ture Retrieval Tool (cDART) through the NationalCenter for Biotechnology Information (NCBI) [46]. This
would suggest that the Ae. aegypti LDL-r may share
similar binding properties of other LRP-type receptors
and therefore could disrupt mammalian LRP-mediated
proteolytic regulation in a kratagonistic fashion. Add-
itionally, a secreted LRP receptor, referred to as sLRP-1
for ‘shed LRP-1’, has recently been found in human
plasma, cerebrospinal fluid, and the brain [47]. This sol-
uble receptor is produced from the full-length LRP-1
protein that is cleaved extracellularly in response to in-
flammation [48]. Further research has determined that
injected sLRP-1 decreases inflammation and neuropathic
pain in a mouse model [49]. Whether the Ae. aegypti
salivary form of this protein deposited at the bite site is
behaving the same way remains to be seen.
Another group of proteins whose expression was signifi-
cantly decreased in DENV-2 infected saliva were the ad-
enosine deaminases, the archetypal protein and a putative
version, 2.8 fold and 5.2 fold, respectively (p ≤ 0.05). An
amino acid sequence comparison between the two
Figure 2 The manifold potential effects of altered salivary proteins on mosquito feeding and DENV transmission. In order to achieve a
successful blood feeding, an infected mosquito might: A1) Increase its salivary, and consequentially viral, inoculum in order to restore a normal level
of anti-hemostatic and pain-reducing salivary proteins relative to an uninfected mosquito; A2) given reduced anti-hemostatic and pain-reducing
salivary proteins, attempt refeeding if (1) the pain perception at the bite site alerts the host or leads to a clot-induced disruption of feeding (2) causing
the mosquito to seek another bite site, increasing overall viral inoculum (3) represented by increasing t (the probability of transmission success) in our
vectorial capacity (VC) equation; B) Alternatively, if this interrupted female moved on to another host in order to acquire a sufficient blood-meal after
a clot-induced or host-triggered interruption, then a subsequent transmission event could occur, even though DENV transmission had previously
occurred during the failed previous feeding attempt, represented by aINF in our VC equation. C) The impacts of these potential transmission enhancements
due to changes in transmission success probability and daily biting rate could yield an increase in the vectorial capacity of the mosquito (ΔVC) relative to
a baseline calculation of VC, and is represented by increasingly darker colors. The x-axis is the difference in probability of transmission success relative to
baseline (tmin = .5) and the y-axis is the difference in in biting rate between uninfected mosquitoes and infected mosquitoes (a-aINF) =Δ(daily biting rate).
Thus the coordinates (0,0) refer to t = .7 (Δ transmission success of .2) and a = aINF (no enhancement to biting rate).
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tity with adenosine deaminase and is slightly larger by
0.692 kDa, in agreement with the almost imperceptible
migration difference in the 2-D gel. Adenosine deaminase
has been shown to convert adenosine at the bite site into
inosine and ammonia, which acts to prevent peripheral
pain signaling [50]. Ribiero et al. noted that the reduction
in adenosine at the bite site by adenosine deaminase was
perplexing due to the fact that adenosine is a vasodialator
and platlet aggregation inhibitor, functions that facilitate
blood-feeding; therefore they concluded that the second-
ary characteristic of pain initiation must trump those func-
tions for a diurnal-feeding mosquito such as Ae. aegypti.
Mosquito salivary nucleosidases, such as the inosine-
uridine preferring nucleoside hydrolase (reduced 7.9 fold,
p ≤ 0.05) and the purine hydrolase (reduced 3.8 fold,
p ≤ 0.05) found during our mass spectrometry-based
identification effort, convert nucleosides into D-ribose
and their respective purine or pyrimidine base with the
addition of water and occasionally the assistance of a diva-
lent cation, such as calcium [51]. While the inosine-
uridine preferring nucleoside hydrolase will hydrolyze
both purines and pyrimidines, the purine hydrolase is spe-
cific for inosine, adenosine, and guanosine [52]. With the
assistance of adenosine deaminase, any adenosine at thebite site would likely be converted into inosine and then
subject to either of the two hydrolases above, leading to
the complete removal of any mast cell degranulation-
inducing products [53]. Given the synergy of these hydro-
lases and adenosine deaminase, it is interesting that all
three were reduced in the DENV-2 infected saliva.
Two serine protease inhibitors (serpins) were identi-
fied via mass spectrometry and were reduced in the
DENV-2 infected saliva. This finding mirrors that of
Bonizzoni et al., who found a reduction in transcripts
for serine proteases in DENV-infected Aedes aegypti
midguts [17]. Both serpins are very similar, sharing 98%
identity when compared at the amino acid level, there-
fore they are likely exhibit similar physiochemical
properties. The protein identified as a salivary anti-
coagulation factor Xa (FXa) serpin was reduced 4.8 fold
(p ≤ 0.05) while the protein identified as serpin-4 was re-
duced 19.4 fold (p ≤ 0.05). The anti-coagulant salivary
anti-FXa serpin was first identified by Stark and James
as a ‘specific, reversible, noncompetitive, proteinaceous
inhibitor of FXa’ [54,55]. This particular serpin is very
similar to an Ae. albopictus-derived anti-FXa serpin
termed ‘alboserpin’ [56]. Due to the detailed biochemical
work done by Calvo et al. on alboserpin demonstrating
binding affinities to heparin and phosolipid vesicles,
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dlethanolamine, and inhibiting FXa; the Ae. aegypti pro-
duced serpins may also share these properties.
The short form of aegyptin, also referred to as SAAG-4
by Boppana et al., was identified previously as being
down-regulated in the salivary gland extract of Ae. aegypti
infected with DENV-2 [24,57]. In agreement with the pre-
vious observation, this same aegyptin was found to be re-
duced in DENV-2 infected saliva by 14.1 fold (p ≤ 0.05).
Beyond aegyptin’s role as an allergen, Calvo and others
have thoroughly analyzed the physiological and bio-
chemical capacities of the archetypal aegyptin molecule
and found that it binds to collagen, inhibiting its inter-
action with platelet glycoprotein IV, integrin α2β1, and
vonWillenbrand factor leading to an overall inhibition
of coagulation [20,58-62]. It is important to note that
this is not the only anti-coagulant protein reduced in
the saliva of DENV-infected Ae. aegypti.
With three known salivary proteins related to the ad-
enosine degrading complex of Ae. aegypti reduced in the
DENV-2 infected saliva, along with a novel low density
lipoprotein receptor that may be involved in the reduc-
tion of pain, it would appear that there is a trend
towards the greater likelihood of both mast cell degranu-
lation and pain perception compared to the same vol-
ume of uninfected mosquito saliva. Considering that the
prevention of detection during feeding is a priority for
Ae. aegypti, due to the fact that it possesses redundant
machinery to remove adenosine, any reduction in ex-
pression of salivary proteins involved in that process
could alert the host to the feeding attempt and lead to
feeding interruptions causing failure to reach repletion.
When combined with a reduction in salivary proteins in-
volved in the prevention of clotting, such as the two ser-
pins and the short form of aegyptin, yet another feeding
pressure would be placed upon the infected mosquito
compared to an uninfected one. If the saliva of an in-
fected mosquito contains less anti-hemostatics on a per
unit volume basis, as suggested from our data, there
would be a greater chance of clot formation occurring
during feeding which could also lead to an interruption in
feeding with a failure to reach repletion. These two mech-
anisms which would hinder an infected mosquito during
feeding could be the physiological basis for the interrup-
tions or delays in feeding by DENV-infected mosquitoes
reported by Platt et al. and Maciel-de-Freitas et al. [63,64].
These changes in salivary composition led us to revise
the method of calculating vectorial capacity- a measure
of transmission potential- of Ae. aegypti, a significant
modifier of which is the biting rate of a vector on
the pathogen-relevant vertebrate population (a) [65,66].
Typical formulations of the equation assume that the
biting rate of mosquitoes is unchanged, regardless of
infection status. However, the reduction in specificproteins identified in this research, combined with the
changes in feeding behavior of DENV-infected mosqui-
toes seen by others, would indicate that this assumption
may be violated in nature and would have consequences
for transmission [63,64,67]. Thus, a separate parameter
of aINF to account for this alteration in vector biting rate
due to infection status is appropriate. Indeed, the trans-
mission differences due to the value of this new param-
eter aINF are not inconsequential. Further, the reduction
of these particular proteins may lead to 1) difficultly in
immediate blood-meal acquisition and thus, additional
probing by a foraging mosquito and 2) vertebrate host
interruption of feeding by the mosquito. The combin-
ation of these two things could enhance the transmission
success of DENV by 1) additional deposition of virus
due to increased probing or 2) additional transmission
events to a new vertebrate host due to probing interrup-
tion. The magnitude of this transmission success prob-
ability will require further experimental investigation,
but given the estimated effects of this measure, this
would merit investigation (Figure 2).
Finally, the remaining protein significantly reduced in
the DENV-2 infected saliva 7.7 fold (p ≤ 0.05) was the
hypothetical protein known through VectorBase.org as
AAEL000732 [33]. Using cDART, no known conserved
domains were identified and VectorBase.org has no in-
formation on suspected function. It would appear that
the role of this protein in the saliva of Ae. aegypti re-
mains to be determined.
Conclusions
In summary, our findings indicate that DENV-2 infection
alters the expression of various salivary proteins in Ae.
aegypti, in particular proteins involved in anti-hemostatic
and pain-reducing capacities. These changes may confer a
fitness advantage upon the virus by enhancing viral estab-
lishment in the vertebrate or by increasing the number of
transmission events. While this work is an important begin-
ning, much remains to be characterized. In particular, the
exact roles these salivary components have at the bite site
within the context of viral deposition remains to be de-
tailed. Restoration of reduced proteins and the resulting
viral dynamics and host responses are currently being in-
vestigated and will likely be of use for vaccine development,
treatment options, and a better understanding of the role of
these critical vector components in arboviral transmission.
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